HDAC9 and infection: Therefore, selected HDAC inhibitors with documented effects in inflammation and infection or cancer24,25 were tested for their ability to reduce intracellular growth of Mtb in human macrophages in comparison to PBA that was used as internal HDAC inhibitor control.